Soros Fund Management’s Alignment Healthcare ALHC Stock Holding History

Soros Fund Management’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-99,800	Closed	-$1.18M	–	212
2022 Q3	$1.18M	Buy	+99,800	New	+$1.46M	0.02%	182

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Soros Fund Management's ALHC Position: Q4 2022 in Review

Soros Fund Management sold out of Alignment Healthcare (ALHC) in Q4 2022, closing a stake of 99,800 shares — an estimated $1.18M sold.

Soros Fund Management first reported a position in ALHC in Q3 2022 and held it in 1 quarter. The position peaked at $1.18M in Q3 2022. 146 funds tracked by Wall St. Rank hold ALHC as of Q4 2022.

Soros Fund Management reported no remaining Alignment Healthcare position as of Q4 2022 after selling out during the quarter.
Soros Fund Management sold 99,800 Alignment Healthcare shares in Q4 2022, an estimated $1.18M.
Soros Fund Management first reported a position in Alignment Healthcare in Q3 2022 and held it in 1 quarter.
Soros Fund Management's Alignment Healthcare position peaked at $1.18M in Q3 2022.
146 funds tracked by Wall St. Rank held Alignment Healthcare as of Q4 2022.

Based on Soros Fund Management's 13F filing for Q4 2022, filed 13 Feb 2023.